Cargando…
Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment
Glioblastoma (GBM) is the most aggressive among the neurological tumors. At present, no chemotherapy or radiotherapy regimen is associated with a positive long-term outcome. In the majority of cases, the tumor recurs within 32–36 weeks of initial treatment. The recent discovery that Zika virus (ZIKV...
Autores principales: | Francipane, Maria Giovanna, Douradinha, Bruno, Chinnici, Cinzia Maria, Russelli, Giovanna, Conaldi, Pier Giulio, Iannolo, Gioacchin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537796/ https://www.ncbi.nlm.nih.gov/pubmed/34681654 http://dx.doi.org/10.3390/ijms222010996 |
Ejemplares similares
-
Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches
por: Badami, Ester, et al.
Publicado: (2022) -
Zika virus infection induces MiR34c expression in glioblastoma stem cells: new perspectives for brain tumor treatments
por: Iannolo, Gioacchin, et al.
Publicado: (2019) -
Two Sides of The Same Coin: Normal and Tumoral Stem Cells, The Relevance of In Vitro Models and Therapeutic Approaches: The Experience with Zika Virus in Nervous System Development and Glioblastoma Treatment
por: Tinnirello, Rosaria, et al.
Publicado: (2023) -
Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment
por: Chinnici, Cinzia Maria, et al.
Publicado: (2021) -
Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection
por: Carreca, Anna Paola, et al.
Publicado: (2022)